Xcenda in the news
Global pharmaceutical market access
Tamtam found 10 recent articles about Xcenda.
- The Xcenda Market Insights Service - Cencora bets on data-led pharma decisions
Cencora's Xcenda unit offers the Market Insights Service, a subscription platform providing detailed U.S. payer data to help pharmaceutical companies make informed reimbursement decisions for specialty and branded drugs.
- Study: Higher Out-of-Pocket Costs Lead to Nonadherence
Research from Xcenda demonstrates that increasing patient out-of-pocket costs negatively impacts medication adherence without providing clear overall cost savings or clinical benefits.
- Drugs left off PBM lists can lead to worse patient outcomes, higher costs
Pharmacy benefit managers exclude more drugs from coverage, potentially worsening patient outcomes and increasing healthcare costs, particularly for chronic conditions.
- PBM Exclusions Increasing, Finds New Analysis
PBM formulary exclusions significantly increased, impacting patient access to medications, including single-source and serious condition treatments, driven by PBM incentives.
- Survey: ICER Assessments Impact Payer Decision-Making
A survey by Xcenda found that most payers utilize ICER assessments as a supporting resource in their decision-making for formulary management, pricing negotiations, and prior authorizations.
- Preparing manufacturers for a changing copay landscape
Drug manufacturers are preparing for significant changes in the copay landscape, driven by accumulator/maximizer programs and a new CMS rule requiring direct patient benefit from assistance.
- Xcenda's Allen Lising Discusses the Growing Emphasis on Biosimilar Pipeline Information
Xcenda's Allen Lising discusses how payers are increasingly seeking biosimilar pipeline information up to 18 months before FDA approval to aid in formulary decisions, highlighting the role of FormularyDecisions in facilitating this information exchange.
- The Power of Innovation: How Technology Facilitates Market & Patient Access
Xcenda's President, Kristine Flemister, discusses how technology facilitates market and patient access for new therapies.
- Optimizing Payer and Manufacturer Communication
A presentation at AMCP Annual Meeting 2018 highlighted the importance of optimizing communication between payers and pharmaceutical manufacturers regarding healthcare economic information to improve patient access and formulary decisions.
- Pharmaceutical consulting firm Xcenda focuses on employees
Xcenda, a pharmaceutical consulting firm, emphasizes a strong employee-focused culture, attracting former interns like Chelsey Campbell back to the company.
Articles collected by Tamtam and kept when they are about the company, newest first. Each links to its source.
Selling to companies like Xcenda?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies